The company will collaborate with Duke on cancer biomarker discoveries, and intends to use and commercialize the markers through agreements with drug developers.
The NC-based startup is led by a former LabCorp executive and is seeking partnerships to bring molecular diagnostic products to market.
In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.
The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.
A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.
Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.